SLC25A4 and Alzheimer disease: The involvement of the mitochondrial ADP:ATP antiporter SLC25A4 in this pathway is particularly interesting, as its altered expression could be linked to mitochondrial function, energy metabolism, and potentially glutamate regulation, all of which are relevant to AD pathology.